Cargando…
Recent advances in chronic lymphocytic leukemia therapy
Chronic lymphocytic leukemia is a genetically heterogeneous disease, and a complex set of genetic alterations is associated with its pathogenesis. CLL is the most common leukemia in the western countries, whereas it is rare in Asia, including Korea. The prognostic models integrate the traditional st...
Autor principal: | Uhm, Jieun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386886/ https://www.ncbi.nlm.nih.gov/pubmed/32719180 http://dx.doi.org/10.5045/br.2020.S012 |
Ejemplares similares
-
Recent therapeutic advances in chronic lymphocytic leukemia
por: Bose, Prithviraj, et al.
Publicado: (2017) -
Recent Advances in CAR T-Cell Therapy for Patients with Chronic Lymphocytic Leukemia
por: Heyman, Benjamin M., et al.
Publicado: (2022) -
Treatment after failure of frontline therapy of chronic myeloid leukemia in chronic phase including allogeneic hematopoietic stem cell transplantation
por: Uhm, Jieun
Publicado: (2023) -
Overview of recent developments in chronic lymphocytic leukemia
por: Jain, Preetesh, et al.
Publicado: (2012) -
Therapeutic advancement of chronic lymphocytic leukemia
por: Lu, Kang, et al.
Publicado: (2012)